• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » China reportedly launches country’s first invasive BCI trial

China reportedly launches country’s first invasive BCI trial

June 16, 2025 By Sean Whooley

Unsplash brain image for brain-computer interfaces blackrock neurotech
[Image from Milad Fakurian on Unsplash]

A report in China claims a hospital has launched the country’s first-in-human clinical trial of an invasive brain-computer interface (BCI).

Global Times reported that the Shanghai-based Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) at the Chinese Academy of Sciences, in collaboration with Fudan University’s Huashan Hospital, launched the trial earlier this year.

According to the report, the trial evaluates a high-throughput, wireless, invasive BCI device. Through minimally invasive surgery, investigators implanted the first such system in a patient with tetraplegia in late March. This patient lost all four of his limbs in a high-voltage electrical accident 13 years ago. The center reportedly said that, after a few weeks of post-operative training, the patient could control electronic devices with his mind.

Since implantation, the device remains stable in the brain with no infection or electrode failure, the report states.

According to the report, CEBSIT anticipates market entry for this BCI device by 2028. Analysts expect a massive boom in the BCI market in the coming decade, citing a $400 billion opportunity.

More about the new BCI system reportedly coming out of China

The researchers reportedly claim that the neural electrodes in this device are the smallest in size and most flexible in the world. They say the electrodes feature a cross-sectional area between a fifth and a seventh the size of the electrodes developed by potential U.S.-based BCI frontrunner Neuralink, while they are reportedly more than 100 times as flexible.

Global Times reports that the implants come in at a diameter of 26 millimeters and a thickness of less than 6 millimeters. Its flexible electrodes feature high-density, wide-ranging, high-throughput and long-term stable in vivo neural signal acquisition capabilities.

Prior validation took place through long-term implantation in rodents, non-human primates and human brains, the report says. Next, the researchers reportedly plan to attempt to let the patient in the trial use a robotic arm. They also hope to explore controlling physical peripherals like robotic dogs, embodies intelligent robots and other intelligent devices.

Filed Under: Brain-Computer Interface (BCI), Clinical Trials, Featured, Health Technology, Implants, Neurological Tagged With: China

More recent news

  • Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
  • Abbott earns Medicare win for TriClip TEER system
  • Judge says Johnson & Johnson Ethicon owes $76.6M to ChemImage after failed partnership
  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy